[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
Publication date
2022-11-28
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl2. HA-1 was found to block microtubule polymerization in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes─themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications.
Keywords
DNA, antiproliferative, cancer, cell cycle, helicene, mitosis, tubulin, Catalysis, General Chemistry, Biochemistry, Colloid and Surface Chemistry, SDG 3 - Good Health and Well-being
Citation
Rushworth, J L, Thawani, A R, Fajardo-Ruiz, E, Meiring, J C M, Heise, C, White, A J P, Akhmanova, A, Brandt, J R, Thorn-Seshold, O & Fuchter, M J 2022, '[5]-Helistatins : Tubulin-Binding Helicenes with Antimitotic Activity', JACS Au, vol. 2, no. 11, pp. 2561-2570. https://doi.org/10.1021/jacsau.2c00435